UCB7853 / UCB, Novartis 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
UCB7853 / UCB, Novartis
NCT04651153: A Safety and Pharmacokinetics Study of UCB7853 in Healthy Study Participants and Study Participants With Parkinson's Disease (PD)

Completed
1
62
Europe
UCB7853, Placebo
UCB Biopharma SRL
Parkinson's Disease
07/23
07/23

Download Options